Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Grayline Clinical Drug Trials
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Department of Psychiatry, University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Department of Psychiatry, University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated:  11/3/2011
Northwest Clinical Research Center
mi
from
East Seattle, WA
Major Depressive Disorder With Mixed Features
A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
Status: Enrolling
Updated: 11/3/2011
Northwest Clinical Research Center
mi
from
East Seattle, WA
Click here to add this to my saved trials
Event Related Potentials in Borderline Personality Disorder and Major Depression
Event Related Potentials in Borderline Personality Disorder and Major Depression
Status: Enrolling
Updated:  11/9/2011
Syracuse University - CNY Medical Center
mi
from
Syracuse, NY
Event Related Potentials in Borderline Personality Disorder and Major Depression
Event Related Potentials in Borderline Personality Disorder and Major Depression
Status: Enrolling
Updated: 11/9/2011
Syracuse University - CNY Medical Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Event Related Potentials in Borderline Personality Disorder and Major Depression
Event Related Potentials in Borderline Personality Disorder and Major Depression
Status: Enrolling
Updated:  11/9/2011
Upstate Medical University
mi
from
Syracuse, NY
Event Related Potentials in Borderline Personality Disorder and Major Depression
Event Related Potentials in Borderline Personality Disorder and Major Depression
Status: Enrolling
Updated: 11/9/2011
Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #023
mi
from
Beverly Hills, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #023
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #017
mi
from
Encino, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #017
mi
from
Encino, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #021
mi
from
Garden Grove, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #021
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #025
mi
from
Newport Beach, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #025
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 009
mi
from
Orange, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 009
mi
from
Orange, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #003
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Research Institute #001
mi
from
Bonita Springs, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Research Institute #001
mi
from
Bonita Springs, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #015
mi
from
Fort Myers, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #015
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #005
mi
from
North Miami, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #005
mi
from
North Miami, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 061
mi
from
Orlando, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 061
mi
from
Orlando, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #004
mi
from
South Miami, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #004
mi
from
South Miami, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Atlanta, GA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 071
mi
from
Prairie Village, KA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 071
mi
from
Prairie Village, KA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Portland, OR
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Portland, OR
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #008
mi
from
Bridgeville, PA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #008
mi
from
Bridgeville, PA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #028
mi
from
Norristown, PA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #028
mi
from
Norristown, PA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Memphis, TN
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 062
mi
from
San Antonio, TX
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 062
mi
from
San Antonio, TX
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Bellevue, WA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #027
mi
from
Seattle, WA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #027
mi
from
Seattle, WA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 007
mi
from
San Diego, CA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 007
mi
from
San Diego, CA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #029
mi
from
Maitland, FL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #029
mi
from
Maitland, FL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Chicago, IL
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Baltimore, MD
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #010
mi
from
Boston, MA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #010
mi
from
Boston, MA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 025
mi
from
St. Louis, MO
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 025
mi
from
St. Louis, MO
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site #011
mi
from
Staten Island, NY
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site #011
mi
from
Staten Island, NY
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 019
mi
from
Philadelphia, PA
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 019
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site
mi
from
Dallas, TX
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/29/2011
Forest Investigative Site 101
mi
from
Kelowna,
Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Relapse-Prevention Study With F2695 SR in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/29/2011
Forest Investigative Site 101
mi
from
Kelowna,
Click here to add this to my saved trials
Pioglitazone in Patients With Mood Disorders
Pioglitazone Treatment for Insulin Resistant Patients With Mood Disorders
Status: Enrolling
Updated:  3/19/2012
Stanford University Department of Psychiatry & Behavioral Sciences
mi
from
Palo Alto, CA
Pioglitazone in Patients With Mood Disorders
Pioglitazone Treatment for Insulin Resistant Patients With Mood Disorders
Status: Enrolling
Updated: 3/19/2012
Stanford University Department of Psychiatry & Behavioral Sciences
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Testing the Effectiveness of a Computer-based Program for Depression
Attention Training for Major Depressive Disorder
Status: Enrolling
Updated:  3/26/2012
University of Texas at Austin
mi
from
Austin, TX
Testing the Effectiveness of a Computer-based Program for Depression
Attention Training for Major Depressive Disorder
Status: Enrolling
Updated: 3/26/2012
University of Texas at Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram
Adjunctive Creatine Treatment for Adolescent Females With Major Depressive Disorder Who Are Non-Responders to Fluoxetine or Escitalopram: A Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated:  4/19/2012
University of Utah
mi
from
Salt Lake City, UT
Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram
Adjunctive Creatine Treatment for Adolescent Females With Major Depressive Disorder Who Are Non-Responders to Fluoxetine or Escitalopram: A Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated: 4/19/2012
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Dichotic Listening as a Predictor of Medication Response in Depression
Dichotic Listening as a Predictor of Placebo and Medication Response in Depression
Status: Enrolling
Updated:  4/26/2012
Depression Evaluation Service - New York State Psychiatric Institute
mi
from
New York, NY
Dichotic Listening as a Predictor of Medication Response in Depression
Dichotic Listening as a Predictor of Placebo and Medication Response in Depression
Status: Enrolling
Updated: 4/26/2012
Depression Evaluation Service - New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Focal Electroconvulsive Therapy for Depression
Focal Electrical Administered Seizure Therapy (FEAST) for Major Depression
Status: Enrolling
Updated:  4/29/2012
Medical University of South Carolina
mi
from
Charleston, SC
Focal Electroconvulsive Therapy for Depression
Focal Electrical Administered Seizure Therapy (FEAST) for Major Depression
Status: Enrolling
Updated: 4/29/2012
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
Comparative Risks for Insulin Resistance and Metabolic Syndrome (MS) Among Hospitalized Patients With Major Depressive Disorder With (MDpsy) or Without (MDD) Psychotic Features
Status: Enrolling
Updated:  4/30/2012
Massachusetts General Hospital
mi
from
Boston, MA
Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
Comparative Risks for Insulin Resistance and Metabolic Syndrome (MS) Among Hospitalized Patients With Major Depressive Disorder With (MDpsy) or Without (MDD) Psychotic Features
Status: Enrolling
Updated: 4/30/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Psychosocial Treatment of Depression in Parkinson's Disease
Psychosocial Treatment of Depression in Parkinson's Disease
Status: Enrolling
Updated:  5/2/2012
Massachusetts General Hospital
mi
from
Boston, MA
Psychosocial Treatment of Depression in Parkinson's Disease
Psychosocial Treatment of Depression in Parkinson's Disease
Status: Enrolling
Updated: 5/2/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Technology-assisted Treatment of Adolescent Depression
Information Technology Enabled Treatment of Adolescent Depression
Status: Enrolling
Updated:  5/8/2012
University of Connecticut Health Center
mi
from
Farmington, CT
Study of Technology-assisted Treatment of Adolescent Depression
Information Technology Enabled Treatment of Adolescent Depression
Status: Enrolling
Updated: 5/8/2012
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Study of Technology-assisted Treatment of Adolescent Depression
Information Technology Enabled Treatment of Adolescent Depression
Status: Enrolling
Updated:  5/8/2012
Woburn Pediatric Associates
mi
from
Woburn, MA
Study of Technology-assisted Treatment of Adolescent Depression
Information Technology Enabled Treatment of Adolescent Depression
Status: Enrolling
Updated: 5/8/2012
Woburn Pediatric Associates
mi
from
Woburn, MA
Click here to add this to my saved trials
Practicing Alternative Techniques to Heal From Depression: The PATH-D Study
Applying Mindfulness-Based Cognitive Therapy to Treatment-Resistant Depression
Status: Enrolling
Updated:  6/12/2012
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Practicing Alternative Techniques to Heal From Depression: The PATH-D Study
Applying Mindfulness-Based Cognitive Therapy to Treatment-Resistant Depression
Status: Enrolling
Updated: 6/12/2012
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Click here to add this to my saved trials
PET Biomarkers in Treatment Resistant Depression
Developing a Biomarker to Predict Response in Treatment Resistant Depression
Status: Enrolling
Updated:  6/26/2012
New York State Psychiatric Institute
mi
from
New York, NY
PET Biomarkers in Treatment Resistant Depression
Developing a Biomarker to Predict Response in Treatment Resistant Depression
Status: Enrolling
Updated: 6/26/2012
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Antidepressant Adherence Via AD_IVR
Antidepressant Adherence Via Telephonic Interactive Voice Recognition (IVR)
Status: Enrolling
Updated:  7/2/2012
Kaiser Permanente Center for Health Research
mi
from
Portland, OR
Antidepressant Adherence Via AD_IVR
Antidepressant Adherence Via Telephonic Interactive Voice Recognition (IVR)
Status: Enrolling
Updated: 7/2/2012
Kaiser Permanente Center for Health Research
mi
from
Portland, OR
Click here to add this to my saved trials
Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression
Potential Use Of Brain Network Activation Analysis Using Evoked Response Potentials to Diagnose Major Depression and Assess Response to Antidepressant Treatment
Status: Enrolling
Updated:  7/2/2012
Depression Clinical and Research Program
mi
from
Boston, MA
Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression
Potential Use Of Brain Network Activation Analysis Using Evoked Response Potentials to Diagnose Major Depression and Assess Response to Antidepressant Treatment
Status: Enrolling
Updated: 7/2/2012
Depression Clinical and Research Program
mi
from
Boston, MA
Click here to add this to my saved trials
Ketamine Infusion for Treatment-resistant Major Depressive Disorder
N-methyl-D-aspartate Antagonist (Ketamine) Infusion for Treatment-resistant Major Depressive Disorder With Suicidal Ideation
Status: Enrolling
Updated:  7/2/2012
Depression Clinical and Research Program, MGH
mi
from
Boston, MA
Ketamine Infusion for Treatment-resistant Major Depressive Disorder
N-methyl-D-aspartate Antagonist (Ketamine) Infusion for Treatment-resistant Major Depressive Disorder With Suicidal Ideation
Status: Enrolling
Updated: 7/2/2012
Depression Clinical and Research Program, MGH
mi
from
Boston, MA
Click here to add this to my saved trials
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Status: Enrolling
Updated:  7/12/2012
MGH Depression Clinical and Research Program
mi
from
Boston, MA
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Mindfulness Based Cognitive Therapy for Chronic Pain and Comorbid Unipolar Depression
Status: Enrolling
Updated: 7/12/2012
MGH Depression Clinical and Research Program
mi
from
Boston, MA
Click here to add this to my saved trials